Intrinsic Value of S&P & Nasdaq Contact Us

Entrada Therapeutics, Inc. TRDA

NASDAQ Global Market

SharesGrow Score
61/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.00
+28.3%

Entrada Therapeutics, Inc. (TRDA) current share price is $14.03. The gold spot price is $4,808.10 per troy ounce. Using the formula: TRDA in gold = $14.03 × 31.1035 ÷ $4,808.10 = 0.0908 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of TRDA when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding TRDA shares over the measured period.

TRDA in US Dollars
Gold in US Dollars
TRDA in Gold (grams per share)

Real Wealth Growth Rate

TRDA
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{TRDA}_{\text{gold}}(t) = \frac{P_{\text{TRDA}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{TRDA}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{TRDA}_{\text{gold}}^{(T)}}{\text{TRDA}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{TRDA}_\text{gold}^{(0)}$ = initial gold-price, $\text{TRDA}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

CNTA
CNTA
Centessa Pharmaceuticals plc
$39.59
+0.05%
OPT
OPT
Opthea Limited
$3.41
+1.49%
CRNX
CRNX
Crinetics Pharmaceuticals, Inc.
$39.75
+2.82%
EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.16
-2.01%
IRON
IRON
Disc Medicine, Inc.
$70.48
+2.95%
TYRA
TYRA
Tyra Biosciences, Inc.
$35.27
-0.98%
PHVS
PHVS
Pharvaris N.V.
$28.68
+2.87%
GLUE
GLUE
Monte Rosa Therapeutics, Inc.
$17.50
-0.28%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message